Tag: Eli Lilly

Industries, Others

Eli Lilly shares are cratering after the FDA rejected a $1 billion arthritis drug on safety concerns

April 18, 2017


Shares of Eli Lilly closed down more than 4 percent Monday after the Food and Drug Administration rejected its drug to treat rheumatoid arthritis. Shares of Incyte, Lilly’s partner on the drug, baricitinib, closed down nearly 11 percent. Wall Street […]